VYNE Therapeutics Inc. revenue breakdown overview

VYNE Therapeutics Inc. revenue for the last year amounted to 501.00 k USD, the most of which — 501.00 k USD — came from its highest performing source at the moment, Chronic Inflammatory and Immune-mediated Therapies, the year earlier bringing 424.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought VYNE Therapeutics Inc. 501.00 k USD, and the year before that — 424.00 k USD.